Princeton, NJ, United States of America

Ainslie Hatch



Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ainslie Hatch: Innovator in Ingestible Event Sensing Technology

Introduction

Ainslie Hatch is an accomplished inventor based in Princeton, NJ (US). He has made significant contributions to the field of medical technology, particularly in the area of ingestible event sensing and analysis. His innovative work has the potential to enhance patient monitoring and medication adherence.

Latest Patents

Ainslie Hatch holds a patent for "Systems, devices, and methods for ingestible event sensing and analysis." This patent describes a system that includes an ingestible signal generator coupled to a medication. The generator is designed to produce a body-transmissible signal upon ingestion by a user. The system also features a receiver equipped with a sensor that detects the body-transmissible signal and generates a sensor signal for wireless transmission. A user device processes this information, monitoring the sensor and generating notifications if the signal is not received within a predetermined time frame. This technology aims to identify trends associated with medication use and improve patient outcomes.

Career Highlights

Ainslie Hatch is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to develop innovative solutions in the healthcare sector. His work focuses on integrating technology with medication management to enhance patient care.

Collaborations

Ainslie has collaborated with notable colleagues, including John P Docherty and Ruth Ross, who contribute to the advancement of their projects and share a commitment to innovation in healthcare technology.

Conclusion

Ainslie Hatch's contributions to ingestible event sensing technology exemplify the intersection of innovation and healthcare. His work not only advances medical technology but also holds promise for improving patient adherence and monitoring.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…